INCR
INCR
NASDAQ · Pharmaceuticals

Intercure Ltd

$3.61
-0.41 (-10.20%)
As of Nov 7, 2:23 AM ET ·
Financial Highlights (FY 2026)
Revenue
1.02B
Net Income
-130,056,854
Gross Margin
14.9%
Profit Margin
-28.4%
Rev Growth
+2.8%
D/E Ratio
0.46
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 14.9% 14.9% 42.1% 42.1%
Operating Margin -28.1% -25.3% 25.4% 23.5%
Profit Margin -28.4% -27.0% 18.6% 18.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.02B 991.15M 56.95M 44.24M
Gross Profit 151.86M 147.68M 23.96M 18.61M
Operating Income -286,802,376 -251,018,319 14.46M 10.41M
Net Income -130,056,854 -113,829,785 10.61M 8.30M
Gross Margin 14.9% 14.9% 42.1% 42.1%
Operating Margin -28.1% -25.3% 25.4% 23.5%
Profit Margin -28.4% -27.0% 18.6% 18.8%
Rev Growth +2.8% +2.8% -4.9% +12.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 22.31M 22.31M 21.12M 16.64M
Total Equity 48.35M 48.35M 85.08M 101.00M
D/E Ratio 0.46 0.46 0.25 0.16
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -69,453,953 -64,165,375 17.54M 14.43M
Free Cash Flow — — 14.62M 7.88M